Felipe Humberto Salech Morales


  • Médico Cirujano ,Universidad Catolica 2007
  • Especialista en Medicina interna , Universidad de Chile
  • Doctor en Ciencias Médicas , Universidad de Chile


Categoría académica:

  • Profesor Asistente Departamento de Neurociencias Facultad de Medicina
  • Profesor Asistente Departamento de Medicina Interna Norte Facultad de Medicina

Linea de Investigación :

Test de navegación virtual detecta de forma rápida y precisa el deterioro cognitivo inicial en personas mayores


  • Vitamin D Increases A beta 140 Plasma Levels and Protects Lymphocytes from Oxidative Death in Mild Cognitive Impairment Patients,CURRENT ALZHEIMER RESEARCH 2018.
  • Cancer Imprints an Increased PARP-1 and p53-Dependent Resistance to Oxidative Stress on Lymphocytes of Patients That Later Develop Alzheimer’s Disease,FRONTIERS IN NEUROSCIENCE 2018.
  • PARP-1 and p53 Regulate the Increased Susceptibility to Oxidative Death of Lymphocytes from MCI and AD Patients,FRONTIERS IN AGING NEUROSCIENCE 2017.
  • Tumor-induced osteomalacia: experience from a South American academic center,OSTEOPOROSIS INTERNATIONAL 2017.
  • Frizzled-1 receptor regulates adult hippocampal neurogenesis,MOLECULAR BRAIN 2016.
  • The role of klotho in the regulation of adult hippocampal neurogenesis,JOURNAL OF THE NEUROLOGICAL SCIENCES,2015.
  • Correction of vitamin d status improves lymphocyte susceptibility to oxidative cell death in mild cognitive impairtment patients,JOURNAL OF THE NEUROLOGICAL SCIENCES 2015.
  • PARP-1 activation and interleukin expression in mild cognitive impairment,JOURNAL OF THE NEUROLOGICAL SCIENCES,2015.
  • Increased Susceptibility to Oxidative Death of Lymphocytes from Alzheimer Patients Correlates with Dementia Severity,CURRENT ALZHEIMER RESEARCH 2014.
  • Inverse Susceptibility to Oxidative Death of Lymphocytes Obtained From Alzheimer’s Patients and Skin Cancer Survivors: Increased Apoptosis in Alzheimer’s and Reduced Necrosis in Cancer,JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES 2012.
  • Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: A case report with a long term follow-up,ANNALS OF HEPATOLOGY 2011.